Skip to Content
Merck
  • A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages.

A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages.

Nature cell biology (2014-10-01)
Haihui Lu, Karl R Clauser, Wai Leong Tam, Julia Fröse, Xin Ye, Elinor Ng Eaton, Ferenc Reinhardt, Vera S Donnenberg, Rohit Bhargava, Steven A Carr, Robert A Weinberg
ABSTRACT

The cell-biological program termed the epithelial-mesenchymal transition (EMT) confers on cancer cells mesenchymal traits and an ability to enter the cancer stem cell (CSC) state. However, the interactions between CSCs and their surrounding microenvironment are poorly understood. Here we show that tumour-associated monocytes and macrophages (TAMs) create a CSC niche through juxtacrine signalling with CSCs. We performed quantitative proteomic profiling and found that the EMT program upregulates the expression of CD90, also known as Thy1, and EphA4, which mediate the physical interactions of CSCs with TAMs by directly binding with their respective counter-receptors on these cells. In response, the EphA4 receptor on the carcinoma cells activates Src and NF-κB. In turn, NF-κB in the CSCs induces the secretion of a variety of cytokines that serve to sustain the stem cell state. Indeed, admixed macrophages enhance the CSC activities of carcinoma cells. These findings underscore the significance of TAMs as important components of the CSC niche.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Phenylmethanesulfonyl fluoride, ≥99.0% (T)
Sigma-Aldrich
Phenylmethanesulfonyl fluoride, ≥98.5% (GC)
Sigma-Aldrich
Rabbit anti-NF-kappaB2 Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.
Sigma-Aldrich
Human Granulocye-Macrophage Colony Stimulating Factor / CSF2 ELISA Kit, for serum, plasma, cell culture supernatant and urine
Sigma-Aldrich
Anti-NEDD9 antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
DAPI, for nucleic acid staining